ABSTRACT
Description Asthma maintenance inhalers are inordinately expensive, inhibiting patients from affording their medication and compromising compliance and adherence and optimal health outcomes. The objective of this article was to examine and highlight the competitive world and challenged opportunity of manufacturers' coupons discounting the inordinate cost of respiratory inhalers and asthma treatment. The cost of asthma treatment, in particular the cost of respiratory medicines, even with health insurance, can be prohibitive (upwards of $700 per month for one inhaler). Medication costs restrict medication access. Compliance and adherence suffer attested by monthly maintenance inhalers being filled less than 50% of the time. Pharmaceutical manufacturers of branded drugs competitively offer and market discount programs designed to help offset out-of-pocket medication (copay or coinsurance) costs. However, these programs vary depending on the manufacturer and are contingent on the parameters of individual insurance plans and their respective pharmacy benefit managers (PBMs). In an attempt to gain market advantage, manufacturers, coupons frequently change criteria making the opportunity of savings for patients and prescribing clinicians difficult to discern, implement and sustain.
Subject(s)
Anti-Allergic Agents/therapeutic use , Antibodies, Anti-Idiotypic/therapeutic use , Antibodies, Bacterial/blood , Antibodies, Monoclonal, Humanized/therapeutic use , Aspergillosis, Allergic Bronchopulmonary/drug therapy , Aspergillus fumigatus/immunology , Immunoglobulin E/blood , Aged, 80 and over , Aspergillosis, Allergic Bronchopulmonary/blood , Aspergillosis, Allergic Bronchopulmonary/diagnosis , Aspergillosis, Allergic Bronchopulmonary/immunology , Aspergillosis, Allergic Bronchopulmonary/microbiology , Biomarkers/blood , Down-Regulation , Humans , Male , Omalizumab , Time Factors , Treatment OutcomeSubject(s)
Financial Management, Hospital/economics , Medicaid/economics , Medically Uninsured/statistics & numerical data , Physicians/economics , Uncompensated Care/economics , Financial Management, Hospital/trends , Hospitalists/economics , Hospitalists/trends , Humans , Medicaid/legislation & jurisprudence , Patient Protection and Affordable Care Act , Physicians/psychology , Physicians/trends , Reimbursement Mechanisms/legislation & jurisprudence , Reimbursement Mechanisms/trends , State Government , Uncompensated Care/trends , United StatesSubject(s)
Deception , Drugs, Generic , Insurance, Health, Reimbursement/economics , Practice Patterns, Physicians'/ethics , Rhinitis, Allergic, Seasonal/drug therapy , Sinusitis/drug therapy , Steroids , Adult , Child , Drugs, Generic/administration & dosage , Drugs, Generic/economics , Ethics, Medical , Female , Humans , Physician-Patient Relations/ethics , Steroids/administration & dosage , Steroids/economics , Truth DisclosureSubject(s)
Anti-Asthmatic Agents/economics , Asthma/drug therapy , Asthma/economics , Fees, Pharmaceutical , Medication Adherence , Adult , Anti-Asthmatic Agents/therapeutic use , Bronchodilator Agents/economics , Bronchodilator Agents/therapeutic use , Humans , Insurance, Health, Reimbursement/economics , Male , Pharmacies/economicsABSTRACT
A DNA-based model system is described for studying electron spin-spin interactions between a paramagnetic metal ion and a nitroxide spin label. The modified base deoxythymidine-EDTA (dT-EDTA) chelates the divalent or trivalent metal ion and produces a new feature in the circular dichroism (CD) spectra that makes it possible to monitor local DNA melting. Based on the results of optical and electron paramagnetic resonance (EPR) experiments, we find that the terminus of the DNA duplex that incorporates dT-EDTA and the spin-label melts at a higher temperature than the rest of the DNA duplex. EPR microwave progressive power saturation experiments performed at 77 K are consistent with the specific binding of Dy(III) at the EDTA site and an intramolecular dipole-dipole interaction between the nitroxide spin-label and the chelated Dy(III). This model system should be suitable for studying the relaxation properties of metal ions by saturation-recovery EPR.
Subject(s)
Cyclic N-Oxides/chemistry , DNA/chemistry , Edetic Acid/analogs & derivatives , Electron Spin Resonance Spectroscopy , Models, Chemical , Spin Labels , Thymidine/analogs & derivatives , Circular Dichroism , Cryoprotective Agents/chemistry , Edetic Acid/chemistry , Electrons , Microwaves , Oligodeoxyribonucleotides/chemistry , Spectrophotometry, Ultraviolet , Thermodynamics , Thymidine/chemistryABSTRACT
BACKGROUND: Current Occupational Safety and Health Administration (OSHA) guidelines mandate the use of safety needles when allergy injections are given. Safety needles for intradermal testing remain optional. Whether safety needles reduce the number of accidental needle sticks (ANSs) in the outpatient setting has yet to be proven. OBJECTIVE: To determine the rate of ANSs with new (safety) needles vs old needles used in allergy immunotherapy and intradermal testing. METHODS: Allergy practices from 22 states were surveyed by e-mail. RESULTS: Seventy practices (28%) responded to the survey. Twice as many ANSs occurred in practices giving immunotherapy when using new needles vs old needles (P < .01). The rate of ANSs was roughly the same for intradermal testing with new needles vs old needles. CONCLUSIONS: These findings further question whether OSHA's guidelines for safety needle use in outpatient practice need revision and if allergy practices might be excluded from the requirement to use safety needles.
Subject(s)
Accident Prevention/legislation & jurisprudence , Allergy and Immunology/instrumentation , Desensitization, Immunologic/instrumentation , Equipment Safety/standards , Intradermal Tests/instrumentation , Needles/standards , Needlestick Injuries/prevention & control , Public Policy , Syringes/standards , United States Occupational Safety and Health Administration/standards , Allergy and Immunology/legislation & jurisprudence , Ambulatory Care/legislation & jurisprudence , Blood-Borne Pathogens , Equipment Contamination , Equipment Design , Health Surveys , Humans , Incidence , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Injections, Subcutaneous/instrumentation , Needlestick Injuries/epidemiology , Practice Guidelines as Topic , Practice Patterns, Physicians'/statistics & numerical data , Safety , United StatesABSTRACT
We have demonstrated the feasibility of linking newborn blood spots, population-based cancer incidence data and birth certificate data. Incident cases of acute lymphocytic leukaemia and population-based controls were ascertained. We retrieved dried blood spot specimens, isolated and amplified DNA, and assayed the cancer susceptibility genes GSTT1 and GSTM1. The double null genotype was over-represented in the cases, consistent with previous reports based on other epidemiological methods. The design avoids issues of participation bias by cases and controls and can be used to investigate interactions of susceptibility genes and xenobiotics in semi-ecological studies. It can be useful for generating or testing hypotheses on associations of other paediatric illness and environmental contaminants.
Subject(s)
Genetic Predisposition to Disease/genetics , Glutathione Transferase/blood , Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics , Case-Control Studies , Child , DNA, Neoplasm/analysis , Genes, Neoplasm/genetics , Genetic Markers/genetics , Genotype , Glutathione Transferase/genetics , Humans , Infant, Newborn , Mothers , Precursor Cell Lymphoblastic Leukemia-Lymphoma/bloodABSTRACT
Surveillance of measles virus detected an epidemiologic link between a refugee from Kenya and a Dutch tourist in New Jersey, USA. Identical genotype B3 sequences from patients with contemporaneous cases in the United States, Canada, and Mexico in November and December 2005 indicate that Kenya was likely to have been the common source of virus.
Subject(s)
Measles virus/classification , Measles/virology , Adolescent , Genotype , Humans , Male , Time FactorsABSTRACT
In total, 1,324 Culex pipiens pipiens L. female mosquitoes were collected at Ft. Hancock, Monmouth County, New Jersey, from January to March 2001-2003. Mosquitoes were held in an insectary at 27 degrees C and a photoperiod of 16:8 (L:D) h for 6 to 21 d after which they were tested in 34 pools. West Nile viral RNA was detected in one pool by a TaqMan reverse transcription-polymerase chain reaction assay; however, infectious virus could not be isolated using either Vero cell plaque assay or C6/36 mosquito cells. Twenty females dissected in January and March 2003 confirmed ovarian diapause status. We suggest that the mode of infection in this pool of overwintering females may have been due to vertical (transgenerational) transmission.
Subject(s)
Culex/virology , RNA, Viral/analysis , Seasons , West Nile virus/genetics , Animals , Female , New Jersey , Reverse Transcriptase Polymerase Chain Reaction , Time FactorsABSTRACT
West Nile virus (WNV) was detected by Taqman reverse transcription-polymerase chain reaction in 4 of 85 (4.7%) blood-engorged (n = 2) and unengorged (n = 2) Icosta americana (Leach) hippoboscid flies that were collected from wild raptors submitted to a wildlife rehabilitation center in Mercer County, NJ, in 2003. This report represents an additional detection of WNV in a nonculicine arthropod in North America and the first documented detection of the virus in unengorged hippoboscid flies, further suggesting a possible role that this species may play in the transmission of WNV in North America.